56 results
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
Stockholder’s voting rights with respect to all such Supporting Stockholder’s Subject Shares (which proxy is irrevocable (and as such will survive
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
with full power of substitution and resubstitution, to the full extent of such Supporting Stockholder’s voting rights with respect to all
SC14D9C
EX-99.3
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
power of substitution and resubstitution, to the full extent of such Stockholder’s voting rights with respect to all such Stockholder’s Subject Shares … or any other interests in any securities of the Company and has no interest in or voting rights with respect to any securities of the Company.
2.4
SC14D9C
EX-99.2
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
power of substitution and resubstitution, to the full extent of such Stockholder’s voting rights with respect to all such Stockholder’s Subject Shares … or any other interests in any securities of the Company and has no interest in or voting rights with respect to any securities of the Company.
2.4
SC14D9C
EX-99.1
gghvr 78m
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.2
wc0guf q5pmx
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.3
ua7 6aet0y
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.1
qxrk a9h271i824u
3 Oct 23
Tender and Support Agreement
7:35am
ARS
1hdk4xuipwjhe
1 May 23
Annual report to shareholders
1:52pm
424B5
3nz2 lva18
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
1wiklw
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
j0tg4s8
11 Jul 22
Prospectus supplement
4:32pm
POS AM
lfdkhnxup76qdskme7k
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
jk5n19w5hc 8ggoqjpvz
1 Jul 22
Shelf registration
4:13pm
424B3
t1zrl1
13 May 22
Prospectus supplement
8:18am